Pfizer amends bylaws to require shareholder disclosure under SEC universal proxy rules

PFIZER INC

Board amended bylaws on Dec 9, 2022, effective immediately.
Shareholders nominating directors must disclose intent to solicit proxies per Rule 14a-19.
Amendments incorporate technical changes to align with SEC's universal proxy rule.
No change to fiscal year; governance update only.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PFIZER INC: Amended and restated by-laws to incorporate universal proxy rule requirements for shareholder director nominations and other technical changes (effective 2022-12-09).

Change: bylaw amendment
Effective: 2022-12-09

Exact text from the filing

On December 9, 2022, the Board of Directors of Pfizer Inc. (the ”Company“) amended and restated the Company’s by-laws (the ”By-laws“).

View on SEC.gov

Browse all governance changes →

PFIZER INC filing history →

Source: SEC EDGAR

accession 0000078003-22-000107

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.